The Effectiveness of Varicella Vaccination in Children in Germany
NCT00679796 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1012
Last updated 2012-10-29
Summary
This study is undertaken to evaluate the effectiveness of currently licensed varicella vaccines under conditions of routine use in a setting where varicella vaccine is included in the childhood immunization calendar.
Conditions
- Varicella (Chickenpox)
- Chickenpox Vaccines
Interventions
- PROCEDURE
-
Varicella (chickenpox) lesion sampling
Sponsors & Collaborators
-
Ludwig-Maximilians - University of Munich
collaborator OTHER - lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-02-29
- Primary Completion
- 2010-10-31
- Completion
- 2010-10-31
Countries
- Germany
Study Locations
More Related Trials
-
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
NCT06740630 ·Status: RECRUITING ·Phase: PHASE3
-
Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
NCT00127010 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination
NCT01866566 ·Status: UNKNOWN ·Phase: PHASE4
-
Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
NCT00127023 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the Philippines
NCT06314724 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine
NCT01817270 ·Status: COMPLETED ·Phase: PHASE4
-
A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age
NCT05084508 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine
NCT02173899 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Children Aged 1-12 Years
NCT06614816 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Long-term Impact of VARIVAX Among Children and Adolescents (V210-036)(COMPLETED)
NCT01077804 ·Status: COMPLETED
-
A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age
NCT06806137 ·Status: RECRUITING ·Phase: PHASE3
-
Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in Children
NCT01982409 ·Status: UNKNOWN ·Phase: PHASE4
-
Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine
NCT02026089 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effectiveness Study of Gardasil on Condyloma
NCT01553994 ·Status: COMPLETED
-
The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose Vaccination
NCT01830283 ·Status: UNKNOWN ·Phase: PHASE4
-
Take Rate, Immunogenicity and Safety of Elstree-BN Smallpox Vaccine in Healthy Vaccinia-Naive Subjects
NCT00189969 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety Study of Live Attenuated Varicella Vaccines in Healthy Adults, Adolescents and Children
NCT02965404 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM).
NCT00792623 ·Status: COMPLETED ·Phase: PHASE2
-
A Blind, Randomized and Controlled Study of Live Attenuated Varicella Vaccines
NCT02981836 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Clinical Trial Assessing the Immunogenicity and Safety of Lyophilized Live-Attenuated Varicella Vaccine in Healthy Subjects Aged 13 to 55 Years
NCT06592456 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine
NCT05669625 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix) Administered in Healthy Adolescents
NCT00534638 ·Status: COMPLETED ·Phase: PHASE4
-
Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056)
NCT00496327 ·Status: COMPLETED ·Phase: PHASE3
-
Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine
NCT00359619 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years
NCT07054099 ·Status: RECRUITING ·Phase: PHASE3